AptarGroup nasal spray tech joins ENA respiratory’s Phase II trial of INNA?051
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
The collaboration highlights the rising importance of intranasal delivery in developing non-vaccine approaches to respiratory disease prevention
Both companies say the collaboration is driven by a shared mission to improve patient outcomes by aligning every step of the diagnostic process
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
KeyCi’s dermatologically tested lineup emphasizes clean formulations—vegan, cruelty-free, alcohol-free, and paraben-free—while being backed by pharmaceutical-grade research and FDA approval
The newly classified assays join Roche’s Ionify 25-Hydroxy Vitamin D total assay in a growing U.S. portfolio
The partnership is designed to close the gap between classroom learning and real-world pharmaceutical practice
The facility supports drug discovery, biomolecular research, and the development of next-generation diagnostics
The initial consideration for the transaction is US$ 12 million
Subscribe To Our Newsletter & Stay Updated